Infinity Pharmaceuticals Stock

Infinity Pharmaceuticals Liabilities

The The Liabilities of Infinity Pharmaceuticals (INFIQ) as of Aug 5, 2026 is 61.20 M USD. In the previous year, The Liabilities was 63.21 M USD — a change of -3.18% (lower).

Liabilities

61.20 MUSD

YoY

-3.18%

Last updated:

In 2026, Infinity Pharmaceuticals's total liabilities amounted to 61.20 M USD, a -3.18% difference from the 63.21 M USD total liabilities in the previous year.

Access this data via the Eulerpool API
Get Free API Key

Infinity Pharmaceuticals Stock analysis

What does Infinity Pharmaceuticals do? Infinity Pharmaceuticals Inc. is a biopharmaceutical company based in Cambridge, Massachusetts. It was founded in 2001 and focuses on the discovery and development of novel therapies for cancer and other serious diseases. Infinity Pharmaceuticals is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Infinity Pharmaceuticals's Liabilities

Infinity Pharmaceuticals's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Infinity Pharmaceuticals's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Infinity Pharmaceuticals's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Infinity Pharmaceuticals's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Infinity Pharmaceuticals’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Infinity Pharmaceuticals stock

The Liabilities of Infinity Pharmaceuticals is 61.20 M USD in 2026.

The Liabilities of Infinity Pharmaceuticals changed from 63.21 M USD to 61.20 M USD, representing a -3.18% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Infinity Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Infinity Pharmaceuticals historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Infinity Pharmaceuticals

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Infinity Pharmaceuticals